174 Peri-Procedural Warfarin Bridging Evaluation for Patients with Atrial Fibrillation Enrolled in an Anticoagulation Management Service

174 Peri-Procedural Warfarin Bridging Evaluation for Patients with Atrial Fibrillation Enrolled in an Anticoagulation Management Service

Saved in:

Bibliographic Details
Main Authors:	Hamza H. Sinan, Katelyn W. Sylvester, Mengyan Li, Ellie M. Kang, Rebecca H. Chow, Jean M. Connors
Format:	Article
Language:	English
Published:	Elsevier 2025-05-01
Series:	Research and Practice in Thrombosis and Haemostasis
Online Access:	http://www.sciencedirect.com/science/article/pii/S2475037925001207
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

The Anticoagulation in Patients with Atrial Fibrillation: Rivaroxaban and Warfarin
by: I. Yu. Koroleva, et al.
Published: (2016-11-01)

The influence of clinical and genetic factors on the stability of warfarin’s anticoagulant effect in patients with atrial fibrillation
by: Ya. M. Mykhailovskyi
Published: (2022-06-01)

Efficiency of the Left Atrial Appendage Thrombus Dissolution in Patients with Persistent Nonvalvular Atrial Fibrillation with Warfarin or Direct Oral Anticoagulants Therapy
by: E. S. Mazur, et al.
Published: (2021-11-01)

Direct Oral Anticoagulants Compared With Warfarin in Patients With Atrial Fibrillation and Valvular Heart Disease Without Mechanical Valves
by: Ghadeer K. Dawwas, et al.
Published: (2025-02-01)

Fibrilação atrial crônica, AVC e anticoagulação: sub-uso de warfarina ? Atrial fibrillation, stroke and anticoagulation: under-use of warfarin?
by: Norberto L. Cabral, et al.
Published: (2004-12-01)

Modern warfarin- dosing algorithms in patients with atrial fibrillation
by: M. Yu. Kolesnyk, et al.
Published: (2015-12-01)

Direct oral anticoagulants vs warfarin in patients with inflammatory bowel disease and atrial fibrillation: a comparative analysis of efficacy and safety
by: Ayoyimika Okunlola, et al.
Published: (2025-07-01)

Comparison between DOACs and warfarin for left atrial thrombus in atrial fibrillation patients
by: Akihiro Sunaga, et al.
Published: (2025-08-01)

Efficacy and Safety of New Oral Anticoagulants versus Warfarin in the Resolution of Atrial Fibrillation with Left Atrial/Left Atrial Appendage Thrombus: A Systematic Review and Meta-Analysis
by: Guan-lian Mo, et al.
Published: (2025-01-01)

CAN CLOPIDOGREL FULLY SUBSTITUTE WARFARIN AND DABIGATRAN IN ATRIAL FIBRILLATION?
by: A. B. Sumarokov
Published: (2013-08-01)

Dabigatran and warfarin in nonvalvular atrial fibrillation or atrial flutter in outpatient clinic practice in Brazil
by: Jean Michell Correia Monteiro, et al.

Renal function decline in Asian patients with atrial fibrillation with warfarin and non‐vitamin K antagonist oral anticoagulants: A report from the COOL‐AF registry
by: Rungroj Krittayaphong, et al.
Published: (2025-04-01)

ANALYSIS OF DIRECT COSTS ASSOCIATED WITH THE USE OF WARFARIN IN PATIENTS WITH ATRIAL FIBRILLATION
by: Yu. B. Belousov, et al.
Published: (2016-01-01)

INCREASED ADHERENCE TO WARFARIN TREATMENT WITH TRAINING PROGRAMS IN PATIENTS WITH ATRIAL FIBRILLATION
by: E. D. Djishambaev, et al.
Published: (2020-12-01)

Graves’ Disease and Treatment Effects on Warfarin Anticoagulation
by: Amanda Howard-Thompson, et al.
Published: (2014-01-01)

WARFARIN: PLACE IN THE ANTICOAGULANT THERAPY TODAY
by: N. A. Novikova, et al.
Published: (2016-07-01)

TIME IN THERAPEUTIC RANGE (TTR) IN ATRIAL FIBRILLATION WITH WARFARIN THERAPY IN SEMARANG, INDONESIA
by: Della Dafina Sekarsari, et al.
Published: (2021-10-01)

Comparative clinical outcomes of acenocoumarol versus direct oral anticoagulants (DOACs) and warfarin in patients with atrial fibrillation: real-world-evidence (SIESTA-A study)
by: Ma Carmen Montero-Balosa, et al.
Published: (2025-08-01)

Anticoagulation in Atrial Fibrillation With Valvular Heart Disease
by: Ana Catarina Fonseca, et al.
Published: (2025-02-01)

Algorithm for the Choice of Anticoagulant for Patients with Atrial Fibrillation
by: Yu. P. Skirdenko, et al.
Published: (2020-05-01)

Atrial Fibrillation Ablation without Interruption of Anticoagulation
by: Pasquale Santangeli, et al.
Published: (2011-01-01)

Drug Interactions and Risk of Bleeding among Patients with Atrial Fibrillation (AF) Discharged with Warfarin
by: Nidal Jaradat, et al.
Published: (2006-09-01)

Platelet and coagulation hemostasis status in patients with atrial fibrillation depending on warfarin dosing method
by: M. Yu. Kolesnyk, et al.
Published: (2022-12-01)

Anticoagulant therapy in catheter ablation of atrial fibrillation and flutter
by: M. V. Serova, et al.
Published: (2021-09-01)

CURRENT POSSIBILITIES OF ANTICOAGULANT THERAPY IN PATIENTS WITH ATRIAL FIBRILLATION
by: M. Yu. Gilyarov, et al.
Published: (2015-10-01)

Anticoagulation therapy in atrial fibrillation after intracranial hemorrhage
by: A. S. Gerasimenko, et al.
Published: (2021-05-01)

Challenges of anticoagulant treatment in atrial fibrillation with liver disease
by: Alina Doina Nicoara, et al.
Published: (2024-10-01)

BRIDGING ANTICOAGULATION IN PATIENTS WHO REQUIRE TEMPORARY INTERRUPTION OF WARFARIN THERAPY FOR AN ELECTIVE INVASIVE PROCEDURE OR SURGERY
Published: (2016-03-01)

75 Comparative Effectiveness and Safety of Direct Oral Anticoagulants Compared with Warfarin in Patients with Low Bodyweight who have Atrial Fibrillation: A Systematic Review and Meta-analysis
by: Mohamed Elshafei, et al.
Published: (2025-05-01)

Left Atrial Appendage Closure in Atrial Fibrillation: A World without Anticoagulation?
by: Tahmeed Contractor, et al.
Published: (2011-01-01)

A CLINICAL CASE OF LYSIS OF THROMBUS IN THE LEFT ATRIAL APPENDAGE IN A PATIENT WITH ATRIAL FIBRILLATION PREVIOUSLY TREATED WITH WARFARIN
by: T. A. Barbashina, et al.
Published: (2020-01-01)

LEFT ATRIAL APPENDAGE CLOSURE AS AN ALTERNATIVE TO WARFARIN FOR STROKE PREVENTION IN ATRIAL FIBRILLATION: A PATIENT¬LEVEL META¬ANALYSIS
Published: (2016-03-01)

Challenges in warfarin versus DOACs for elderly atrial fibrillation: A critique of Takagi and Ueda's study
by: Sanjana, et al.
Published: (2025-06-01)

SPECIAL CONSIDERATIONS REGARDING WARFARIN DOSE TITRATION IN PATIENTS WITH ATRIAL FIBRILLATION DEPENDING ON CLINICAL FACTORS
by: E. L. Artanova, et al.
Published: (2016-01-01)

Efficacy and safety of warfarin therapy in patients with atrial fibrillation using genotype-guided dosing method
by: M. Yu. Kolesnyk, et al.
Published: (2022-09-01)

Efficacy and safety of non‐vitamin K antagonist oral anticoagulants versus warfarin in atrial fibrillation and kidney failure under hemodialysis: A meta‐analysis of controlled randomized trials
by: Ting‐Yung Chang, et al.
Published: (2025-06-01)

Adherence to oral anticoagulation in ischemic stroke patients with atrial fibrillation
by: Paula Tiili, et al.
Published: (2021-01-01)

Specifics of anticoagulation in combination with atrial fibrillation and chronic kidney disease
by: N. Sh. Zagidullin, et al.
Published: (2021-10-01)

Contribution of anticoagulant therapy adherence to the risk of complications of atrial fibrillation
by: Yu. P. Skirdenko, et al.
Published: (2019-03-01)

NOVEL ANTICOAGULANTS FOR THROMBOEMBOLIC COMPLICATIONS PREVENTION IN NONVALVULAR ATRIAL FIBRILLATION
by: D. A. Itkin, et al.
Published: (2015-02-01)